Amphastar Pharmaceuticals, Inc. Share Price & Technical Analysis

AMPH · $18.41 (+1.38%)

Healthcare / Drug Manufacturers - Specialty & Generic

AI Score 29 · Bearish

$18.41

+1.38%

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for the temporary relief of mil

Price chart

Seasonality

May has 4 positive and 1 negative years (last 5 years shown)

-16% return in May, 11% avg return in past 3 year May month.

-33% return in 2026, 8% avg return in past 3 years.

Swipe sideways to see all months →

JanFebMarAprMayJunJulAugSepOctNovDecYr
26-1%-23%-3%12%-16%-33%
25-7%-17%2%-16%6%-10%-8%46%-14%-4%9%-2%-14%
24-14%-13%-7%-6%2%-5%12%12%0%4%-11%-17%-43%
238%6%11%-5%23%29%3%-13%-14%-2%25%9%81%
22-1%20%29%-2%5%-7%7%-20%-5%9%-5%-5%25%

Monthly return % by calendar month · historical pattern, not a forecast

AI snapshotScore 29/100

Bearish · Downtrend · Neutral

Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. It offers BAQSIMI, a dry nasal spray used in an emergency for the treatment of severe hypoglycemia; Primatene MIST, an epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Glucagon for injection emergency kit; Enoxaparin, an injectable form of low molecular weight heparin for the prevention and treatment of deep vein thrombosis; and REXTOVY and Naloxone for opioid overdose. The company also provides Cortrosyn, a lyophilized power for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency; Amphadase, a bovine-sourced hyaluronidase injection; Epinephrine injection for allergic reactions; Lidocaine jelly, an anesthetic product for urological procedures; Lidocaine topical solution for various procedures; Phytonadione injection, a vitamin K1 injection for newborn babies; and emergency syringe products, including atropine, calcium chloride, dextrose, epinephrine, lidocaine, and sodium bicarbonate. In addition, it offers Albuterol sulfate inhalation aerosol for the treatment or prevention of bronchospasm; Iron sucrose injection, an iron replacement product for the treatment of iron deficiency anemia in patients with chronic kidney disease; Teriparatide injection for managing daily osteoporosis therapy; and Ipratropium Bromide HFA inhalation aerosol, an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease. Further, the company provides active pharmaceutical ingredient (API) products, such as Recombinant Human Insulin and porcine insulin API. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Full AI Q&A, portfolio tracking, and live alerts in the app.

Key metrics

Market cap

$767.66M

P/E ratio

10.49

52W high

$31.26

52W low

$16.65

Volume

4,74,116

Beta

0.97

Related stocks in Healthcare

Frequently asked questions

What is Amphastar Pharmaceuticals, Inc. share price today?
Amphastar Pharmaceuticals, Inc. (AMPH) last traded around $18.41 on StockPro. Prices refresh every few minutes during market hours.
What technical signals does AMPH have?
StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for AMPH. Download the app for real-time alerts.
How can I analyze Amphastar Pharmaceuticals, Inc. stock?
Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.

Explore more on StockPro